Literature DB >> 20375547

Enhancement of antiviral activity of collectin trimers through cross-linking and mutagenesis of the carbohydrate recognition domain.

Mitchell R White1, Patrick Boland, Tesfaldet Tecle, Donald Gantz, Grith Sorenson, Ida Tornoe, Uffe Holmskov, Barbara McDonald, Erika C Crouch, Kevan L Hartshorn.   

Abstract

Surfactant protein D (SP-D) plays important roles in innate defense against respiratory viruses [including influenza A viruses (IAVs)]. Truncated trimers composed of its neck and carbohydrate recognition domains (NCRDs) bind various ligands; however, they have minimal inhibitory activity for IAV. We have sought to find ways to increase the antiviral activity of collectin NCRDs. Cross-linking of the SP-D NCRD with nonblocking monoclonal antibodies (mAbs) markedly potentiates antiviral activity. In the present report, we demonstrate that F(ab')2 [but not F(ab')1] fragments of a cross-linking mAb have similar effects. Hence, cross-linking activity, but not the Fc domain of the mAb, is needed for increased antiviral activity. In contrast, the Fc domain of the mAb was important for increasing viral uptake or respiratory burst responses of human neutrophils. Our NCRD constructs contain an S protein binding site. Herein, we show that a multivalent S protein complex caused cross-linking and also increased the antiviral activity of NCRDs. NCRDs of conglutinin and CL43 had greater intrinsic antiviral activity than those of SP-D or mannose-binding lectin. Based on motifs found in these serum collectins, we have constructed mutant versions of the human SP-D NCRD that have increased antiviral activity. These mutant NCRDs also had potentiated activity after cross-linking with F(ab')2 fragments or S protein complexes. Hence, the antiviral activity of NCRDs can be increased by 2 distinct, complementary strategies, namely cross-linking of NCRDs through various means and mutagenesis of CRD residues to increase viral binding. These findings may be relevant for antiviral therapy. (c) 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20375547      PMCID: PMC2956016          DOI: 10.1159/000272313

Source DB:  PubMed          Journal:  J Innate Immun        ISSN: 1662-811X            Impact factor:   7.349


  41 in total

1.  By binding SIRPalpha or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation.

Authors:  Shyra J Gardai; Yi-Qun Xiao; Matthew Dickinson; Jerry A Nick; Dennis R Voelker; Kelly E Greene; Peter M Henson
Journal:  Cell       Date:  2003-10-03       Impact factor: 41.582

2.  A recombinant fragment of human surfactant protein D reduces alveolar macrophage apoptosis and pro-inflammatory cytokines in mice developing pulmonary emphysema.

Authors:  Howard Clark; Nades Palaniyar; Samuel Hawgood; Kenneth B M Reid
Journal:  Ann N Y Acad Sci       Date:  2003-12       Impact factor: 5.691

3.  Mechanisms of anti-influenza activity of surfactant proteins A and D: comparison with serum collectins.

Authors:  K L Hartshorn; M R White; V Shepherd; K Reid; J C Jensenius; E C Crouch
Journal:  Am J Physiol       Date:  1997-12

4.  Interactions of recombinant human pulmonary surfactant protein D and SP-D multimers with influenza A.

Authors:  K Hartshorn; D Chang; K Rust; M White; J Heuser; E Crouch
Journal:  Am J Physiol       Date:  1996-11

5.  Treatment of influenza A (H1N1) virus infections in mice and ferrets with cyanovirin-N.

Authors:  Donald F Smee; Kevin W Bailey; Min-Hui Wong; Barry R O'Keefe; Kirk R Gustafson; Vasiliy P Mishin; Larisa V Gubareva
Journal:  Antiviral Res       Date:  2008-07-02       Impact factor: 5.970

6.  Conglutinin acts as an opsonin for influenza A viruses.

Authors:  K L Hartshorn; K Sastry; D Brown; M R White; T B Okarma; Y M Lee; A I Tauber
Journal:  J Immunol       Date:  1993-12-01       Impact factor: 5.422

7.  Human neutrophil defensins increase neutrophil uptake of influenza A virus and bacteria and modify virus-induced respiratory burst responses.

Authors:  Tesfaldet Tecle; Mitchell R White; Don Gantz; Erika C Crouch; Kevan L Hartshorn
Journal:  J Immunol       Date:  2007-06-15       Impact factor: 5.422

8.  Reduced influenza viral neutralizing activity of natural human trimers of surfactant protein D.

Authors:  Kevan L Hartshorn; Mitchell R White; Tesfaldet Tecle; Ida Tornoe; Grith L Sorensen; Erika C Crouch; Uffe Holmskov
Journal:  Respir Res       Date:  2007-02-05

9.  Role of viral hemagglutinin glycosylation in anti-influenza activities of recombinant surfactant protein D.

Authors:  Kevan L Hartshorn; Richard Webby; Mitchell R White; Tesfaldet Tecle; Clark Pan; Susan Boucher; Rodney J Moreland; Erika C Crouch; Ronald K Scheule
Journal:  Respir Res       Date:  2008-09-23

10.  Truncated recombinant human SP-D attenuates emphysema and type II cell changes in SP-D deficient mice.

Authors:  Lars Knudsen; Matthias Ochs; Rosemarie Mackay; Paul Townsend; Roona Deb; Christian Mühlfeld; Joachim Richter; Fabian Gilbert; Samuel Hawgood; Kenneth Reid; Howard Clark
Journal:  Respir Res       Date:  2007-10-03
View more
  10 in total

Review 1.  Why Glycosylation Matters in Building a Better Flu Vaccine.

Authors:  Deborah Chang; Joseph Zaia
Journal:  Mol Cell Proteomics       Date:  2019-10-11       Impact factor: 5.911

2.  Mutagenesis of surfactant protein D informed by evolution and x-ray crystallography enhances defenses against influenza A virus in vivo.

Authors:  Erika Crouch; Nikolaos Nikolaidis; Francis X McCormack; Barbara McDonald; Kimberly Allen; Michael J Rynkiewicz; Tanya M Cafarella; Mitchell White; Kara Lewnard; Nancy Leymarie; Joseph Zaia; Barbara A Seaton; Kevan L Hartshorn
Journal:  J Biol Chem       Date:  2011-09-30       Impact factor: 5.157

3.  Monoclonal antibody-assisted structure-function analysis of the carbohydrate recognition domain of surfactant protein D.

Authors:  Kevan L Hartshorn; Mitchell R White; Michael Rynkiewicz; Grith Sorensen; Uffe Holmskov; James Head; Erika C Crouch
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-07-02       Impact factor: 5.464

4.  Mutations flanking the carbohydrate binding site of surfactant protein D confer antiviral activity for pandemic influenza A viruses.

Authors:  Nikolaos M Nikolaidis; Mitchell R White; Kimberly Allen; Shweta Tripathi; Li Qi; Barbara McDonald; Jeffery Taubenberger; Barbara A Seaton; Francis X McCormack; Erika C Crouch; Kevan L Hartshorn
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-04-04       Impact factor: 5.464

Review 5.  Soluble host defense lectins in innate immunity to influenza virus.

Authors:  Wy Ching Ng; Michelle D Tate; Andrew G Brooks; Patrick C Reading
Journal:  J Biomed Biotechnol       Date:  2012-05-16

Review 6.  The Role and Molecular Mechanism of Action of Surfactant Protein D in Innate Host Defense Against Influenza A Virus.

Authors:  I-Ni Hsieh; Xavier De Luna; Mitchell R White; Kevan L Hartshorn
Journal:  Front Immunol       Date:  2018-06-13       Impact factor: 7.561

7.  Involvement of Surfactant Protein D in Ebola Virus Infection Enhancement via Glycoprotein Interaction.

Authors:  Anne-Laure Favier; Olivier Reynard; Evelyne Gout; Martin van Eijk; Henk P Haagsman; Erika Crouch; Viktor Volchkov; Christophe Peyrefitte; Nicole M Thielens
Journal:  Viruses       Date:  2018-12-26       Impact factor: 5.048

8.  Protective effect of surfactant protein d in pulmonary vaccinia virus infection: implication of A27 viral protein.

Authors:  Julien Perino; Nicole M Thielens; Erika Crouch; Danièle Spehner; Jean-Marc Crance; Anne-Laure Favier
Journal:  Viruses       Date:  2013-03-21       Impact factor: 5.048

Review 9.  Innate Immunity and Influenza A Virus Pathogenesis: Lessons for COVID-19.

Authors:  Kevan L Hartshorn
Journal:  Front Cell Infect Microbiol       Date:  2020-10-22       Impact factor: 5.293

10.  Viral Evasion of Innate Immune Defense: The Case of Resistance of Pandemic H1N1 Influenza A Virus to Human Mannose-Binding Proteins.

Authors:  Mitchell R White; Nikolaos M Nikolaidis; Francis McCormack; Erika C Crouch; Kevan L Hartshorn
Journal:  Front Microbiol       Date:  2021-12-08       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.